CV/COS Webinar: Clip 7

Clinical trials are essential for testing new treatments, but they often focus on a specific group of patients, the healthiest among those with the disease. However, real-world data platforms like Carevive’s offer a broader perspective. By incorporating data from various clinical settings, we gain insights into the entire population of patients with a particular condition. This comprehensive approach allows us to better understand the complexities of oncology and explore treatment outcomes beyond the confines of clinical trials. Real-world data is a powerful tool that complements clinical trials, helping us improve cancer care for all patients.

Recent Episodes

The Rothman Index, developed by Dr. Michael Rothman and his brother Steven, is a pioneering patient acuity score designed to help clinicians recognize patient deterioration earlier and more clearly. Presented as an easily understood, color-coded graph that updates in real time, the Index displays upward and downward trends in patient condition at a glance—transforming…

Hospitals collect enormous amounts of clinical data, yet preventable patient decline remains a persistent challenge. Over the past two decades, hospitals have invested heavily in early warning scores and rapid response infrastructure, but translating data into timely, meaningful action has proven difficult. As clinicians contend with alert fatigue and increasing documentation burden, a more…

Healthcare generates enormous volumes of clinical data, yet making sense of that information in real time remains a challenge. Subtle changes in vitals, labs, and nursing assessments often precede serious events, but when that information is fragmented across the medical record, emerging risks can go unnoticed. The central challenge facing hospitals today is not…